Cargando…
Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health Organization (WHO). As the world faces the coronavirus disease 2019 crisis, the oncology community is being impacted by unpreceden...
Autores principales: | Jacome, Lizbeth Soto, Deshmukh, Sachin Kumar, Thulasiraman, Padmamalini, Holliday, Nicolette Paolaungthong, Singh, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813454/ https://www.ncbi.nlm.nih.gov/pubmed/33469377 http://dx.doi.org/10.2147/CMAR.S287152 |
Ejemplares similares
-
Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2016) -
Involvement of Fatty Acid Binding Protein 5 and PPARβ/δ in Prostate Cancer Cell Growth
por: Morgan, Elwin, et al.
Publicado: (2010) -
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2014) -
Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2017) -
ETV4: an emerging target in pancreatic cancer
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2018)